用户名:  密码:   
网站首页即时通讯活动公告最新消息科技前沿学人动向两岸三地人在海外历届活动关于我们联系我们申请加入
栏目导航 — 美国华裔教授专家网科技动向生物医学
关键字  范围   
 
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
2020/8/8 18:53:49 | 浏览:101 | 评论:0
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
 
     
TOP STORIES
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
  SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
 
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
 
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
  SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
  SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
BIOPROCESSING
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
  SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
  SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
CANCER & DISEASE RESEARCH Sponsored by Beckman Coulter
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
  SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
  SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
  SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
  SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
CELL BIOLOGY
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
  SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
  SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
  SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
  SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
DRUG DISCOVERY & DEVELOPMENT
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
  SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
  SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
  SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
  SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
  SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
  SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
  SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
  SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
  SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
GENOMICS Sponsored by Nvidia
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
  SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
  SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
  SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
  SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
IMMUNOLOGY Sponsored by Beckman Coulter
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
  SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
  SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
  SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
  SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
  SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
  SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
  SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
PROTEOMICS
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
  SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
  SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapiesInsights
Exclusive content for Science Advisory Board members on trends and outcomes that are influencing the future of scientific research.
 
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapiesCommunities
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
 
SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapiesRewards
Earn points for contributing to research. Redeem your points for merchandise, travel, or even to help your favorite charity.
 
 

 

Dear Science Advisory Board Member,

As more molecular coronavirus research becomes published, we are getting a better view of the SARS-CoV-2 virus and its pathogenicity. Particularly, how the virus leverages nonstructural proteins to undermine host immune defenses and how blocking these proteins may effectively stop the virus in its tracks. More detailed molecu lar views of these accessory proteins will guide structure-based drug design and bring us one step closer to beating this pandemic.

As an example, researchers from the U.S. National Institutes of Health(NIH)and other academic institutions in the U.S. described how they rapidly developed a SARS-CoV-2 vaccine candidate based on the genetic sequences of the virus and previous work with messenger RNA(mRNA)vaccine delivery systems.

This vaccine candidate, mRNA-1273, is being jointly developed by the NIH and Moderna and is part of the agency's large-scale clinical trial protocol, Accelerating COVID-19 Therapeutic Interventions and Vaccines(ACTIV). The program includes both vaccines and treatments, and the NIH announced that it has launched phase II studies for the investigational monoclonal antibody Ly-CoV555 developed by Eli Lilly and AbCellera.

Other contenders, like Johnson & Johnson's Ad-26 and Inovio's Ino-4800, are posting positive preclinical results and their developers expect to begin late-stage clinical testing soon. Funding through the U.S. government's Operation Warp Speed program is still being allocated to new vaccine candidates, such as a recombinant protein-based vaccine being developed by Sanofi and GlaxoSmithKline.

Aside from COVID-19 developments, several notable advances in immunotherapies and gene therapies were announced this week. Bio-Rad won an important patent infringement appeal over 10X Genomics, which gives it an edge in the gene expression products market. Meanwhile, Omega Therapeutics is advancing its epigenomic programming platform in clinical trials, and SAB Therapeutics has begun testing a seasonal flu immunotherapy.

Stay healthy and safe.

SARS-CoV-2 structure informs clinical trials | Progress in gene therapies, immunotherapies
Samantha Black, PhD
The Science Advisory Board Editor
editor@scienceboard.net
相关栏目:『生物医学
身体自带“排毒系统” 饮食“排毒”都是忽悠! 2020-09-27 [35]
有望避免耐药性 加州大学旧金山分校新方法让抗生素合成不再漫长 2020-09-26 [52]
莫斯科工程物理学院找到宫颈癌前病变PDT诊疗新方法 2020-09-24 [62]
日本东北大学和理化学研究所最新研究发现:敲鼓改善老年人认知功能 2020-09-13 [133]
宾夕法尼亚大学研究人员进行胰岛细胞皮下移植动物试验成功 2020-09-10 [101]
弗吉尼亚大学医学院新研究发现:运动可延缓、预防常见致盲眼病 2020-09-10 [110]
澳大利亚昆士兰大学新研究表明:女性体重超标更易更年期不适 2020-09-10 [120]
《Oncology Research》 一次性被曝36篇论文造假,全部来自大陆医院 2020-09-09 [220]
综述:靶向CD47抗肿瘤抗体的临床前和临床研究进展 2020-09-06 [92]
希望之城抗癌突破!溶瘤病毒“点燃”CAR-T疗法,一半以上小鼠被治愈 2020-09-06 [147]
相关栏目更多文章
最新图文:
:天安门广场喜迎“十一”花团锦簇的美丽景象 :Daily Journal董事会主席芒格:中国的水还行, 聪明人已经趟进去了 陈沉:FDA称雷尼替丁存在致癌物 Sandoz药物销售被叫停 :印裔人才在美碾压华裔:我们可以从印度教育中学到什么? :假如美国大学们都有一句诚实的Slogan :北京452万人将从北京迁至雄安(附部分央企名单) :《2019全球肿瘤趋势报告》 :美国大学的论文代写究竟猖狂到什么地步?
更多最新图文
更多《即时通讯》>>
 
打印本文章
 
您的名字:
电子邮件:
留言内容:
注意: 留言内容不要超过4000字,否则会被截断。
未 审 核:  是
  
关于我们联系我们申请加入后台管理设为主页加入收藏
美国华裔教授专家网版权所有,谢绝拷贝。如欲选登或发表,请与美国华裔教授专家网联系。
Copyright © 2020 ScholarsUpdate.com. All Rights Reserved.